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and mesenchymal stem cell markers (CD44 (Hermes antigen,
hyaluronan receptor), CD90 (Thy-1), cadherin-11 showed in-
creased expression levels. Both mixed and puriﬁed synovial cells
were negative for markers of haematopoeetic progenitors (CD34)
and further developmental stages of blood cells (CD11b, CD45)
(Fig. 1).
The chondrogenic differentiation and proliferative potential of
MSCP and SFB cells were compared using biochemical and
histological analyses (Fig. 2).
Figure 2. Comparison of the proliferative and chondrogenic potential of mixed
synovial cell population (MSCP) with the puriﬁed type-B synovial ﬁbroblasts
(SFB) cultivated for 7 days with 20 ng/ml TGF-β1. (a) DNA and (b) GAG per
pellet, (c) histological cross-sections of MSCP-pellets and SFB-pellets depicting
staining for GAG (Safranin-O/Fast Green) and type II collagen (immunohisto-
chemistry) – Scale bars are 200 μm. (d) Relative mRNA expression of aggre-
can, type II collagen, and type I collagen genes in the SFB-pellets with respect to
those in the MSCP-pellets. Data presented as mean ± SD, *p<0.05, **p<0.01,
n=3.
Conclusions: We have demonstrated the cells from mammalian
synovium contain a mesenchymal stem cell population capable of
chondrogenic differentiation and that the CD14-negative isolation
yields an enhanced cell population (SFB) that is more potent than
MSCP as a cell source for cartilage tissue engineering.
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Purpose: Cartilage injuries are a common clinical problem and as
this tissue possesses limited self-renewal potential, any damage to
this tissue, such as those arising from sports injuries, osteoarthritis
and rheumatoid arthritis will eventually result in loss of cartilage
with possible exposure of the subchondral bone and resultant pain
and immobility.
The World Health Organisation (WHO) has shown that the burden
to society of these disorders is not only signiﬁcant in terms
of absolute disability-adjusted-life years (DALYs) but that it is
seen (and is growing) in both the developed and developing
world. Strategies for the assisted repair of skeletal tissues are
urgently required to alleviate the high morbidity associated with
joint disorders.
Current therapies are restricted by shortage of grafting material,
insufﬁcient biocompatibility of the implanted material and absence
of cells with reparative potential. The unique biological properties
of human embryonic stem cells (hESCs) highlight them as ideal
candidate cell sources for such therapies by virtue of their directed
differentiation potential and their ability to undertake large scale
proliferation for bulking up prior to use.
The aim of this study was to produce hESC-derived chondropro-
genitor cells and to investigate their potential to repair an articular
cartilage defect in the rat knee.
Methods: Cells from a registered hESC line were expanded in
feeder free conditions using established techniques. Embryoid
body-derived cells were cultured using an in-house deﬁned me-
dia system capable of inducting chondrogenic differentiation to
form 3D cell constructs. Markers of chondrogenic differentiation
were monitored in constructs prior to use experimentally. Pre-
labeling with the ﬂuorescent cellular probe CM-Dil (20μM; Molec-
ular Probes™) allowed tracking of implanted human cells in the
rat defect. Defects were created surgically on the femoropatellar
groove of the knee joint of rats and the constructs were implanted.
Empty defects served as controls.
Samples were collected 21 days post-implantation and snap
frozen. Fixed cryosections were assessed both morphologically
and histologically for repair and to track the persistence of im-
planted human cells. A subset of constructs were collected at
the time of implantation to enable characterisation of implanted
material.
Results: HESC-derived constructs exhibited a chondrogenic phe-
notype at the time of implantation as shown by IHC and gene
expression of articular cartilage speciﬁc Collagen II. Following 21
days implantation, the regenerate tissue not only showed good
integration with the host tissue but also a hyaline cartilage-like
morphology and excellent values when scored using a modiﬁed
system based on scoring systems devised by Wakitani and Ho-
raf for markers of healthy cartilage. In comparison, empty defects
showed poor repair with a ﬁbrocartilaginous tissue ﬁlling the defect
area. The presence of CM-Dil labeled cells within the defect area
demonstrated the persistence of donor cells.
Conclusions: This study points to the future use of hESC-derived
chondrogenic cells in the treatment of cartilage defects in man.
The ultimate aim of our work is to address the huge disease burden
associated with osteoarthritis and future studies will focus on ways
to support the chondrogenic cells in the harsh OA environment.
Acknowledgements: This work was funded by Geron Corporation
and UK Stem Cell Foundation/MRC/Scottish Enterprise.
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Purpose: Articular cartilage shows poor intrinsic repair, leading
to progressive joint damage. Therapies like marrow stimulation or
tissue engineering depend on chondrogenesis of progenitor cells.
However, chondrogenesis needs to take place in a joint with a
distorted environment. We have shown that factors produced by
osteoarthritic (OA) synovium inhibit chondrogenesis of progenitor
cells. To elucidate which pathways are responsible for this inhibition
microarray analysis was performed on chondrogenic progenitor
cells treated with OA synovium- derived conditioned medium.
Methods: Human mesenchymal stem cells (hMSC) were chon-
drogenically differentiated. Cells were pelleted in serum free chon-
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drogenic medium supplemented with TGF-beta and BMP-2. OA
synovium-derived conditioned medium was obtained by cultur-
ing synovium from OA patients during 24 hours in chondrogenic
medium.
Conditioned medium was added to hMSC undergoing chondro-
genesis. Chondrogenesis was examined by determining mRNA
levels of chondrogenic markers COL2A1 (collagen type II) and
ACAN (aggrecan), as well as safranin O proteoglycan staining
on histological sections.Microarray analysis (Affymetrix) was per-
formed on day 4 and conditioned medium was added 24 hours
prior to sampling. Microarray data were analyzed using Ariadne
pathway software. Three chondrogenic pellets were pooled to
obtain 8 array samples in total; 3 Non catabolic control (NCC)
samples without conditioned medium and 4 samples treated with
conditioned medium of 4 different OA patients (OA). Additionally
1 sample was treated with conditioned medium derived from a
patient exhibiting no clear OA symptoms (AnOA).
Results: Chondrogenesis was induced in the hMSC strongly at
2 weeks under the described anabolic conditions (NCC). Condi-
tioned media of the 4 different OA patients (OA) inhibited chondro-
genesis of hMSC. The AnOA conditioned medium exerted a slight
anabolic effect on chondrogenesis.
Biological triplicate NCC displayed a stronger Pearson’s correlation
(0.992 - 0.993) than the 4 OA samples (0.989 - 0.990). The NCC
and OA showed the least resemblance (0.983 - 0.990).The AnOA
resembled the NCC (0.989 - 0.991) more closely than the OA
(0.985 - 0.991), which was conﬁrmed by hierarchical clustering.
A set of regulated genes was determined, deﬁned by at least a
2 fold change (FC) from NCC as well as AnOA in 3 or 4 OA
samples. This list included 60 genes that were upregulated (HIGH
in OA) and 20 genes downregulated (high in NCC and AnOA).
The top regulated genes included CXCL6 (21.7 FC), CXCL5 (19.9
FC), SLC7A2 (7.6 FC), CXCL1 (7.5 FC), PI15 (7.4 FC), CRYGS
(7.4 FC Down), AREG (6.2 FC), SAA1 (6.1 FC), OMD (5.4 FC
Down), MMP3 (5.2 FC) and MMP13 (5.1 FC).
Pathway enrichment analysis was performed on the set of regu-
lated genes, their regulators (126 genes) and targets (80 genes) as
determined automatically by Ariadne Pathway software (p=0.01,
6 or more genes enriched). Pathways identiﬁed in this manner
included ELK-SRF (33 hits), STAT (30 hits), CREB (29 hits), AP-1
(25 hits) and NF-kB (16 hits).
Conclusions: The AnOA condition exhibited a slight stimulatory
effect on chondrogenesis. This sample appeared a suitable con-
trol in addition to NCC as conﬁrmed by PCA and hierarchical
clustering analysis. This indicates that conditioned medium has
no deleterious effects on chondrogenesis. We detected the ELK-
SRF, STAT, CREB, AP-1 and NF-kB pathways to be activated by
OA conditioned medium. Modulating these pathways may improve
chondrogenesis in conditions such as in OA.
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Purpose: Microfracture of the subchondral bone can lead to ar-
ticular cartilage regeneration through mechanisms critically tied to
the repair of damaged trabecular bone. Better understanding of
how bone marrow stromal cells (BMSCs) repair damaged sub-
chondral bone could lead to the development of novel cartilage
repair strategies. The purpose of this study was to further eluci-
date the mechanisms of BMSC osteogenesis using an in vitro cell
culture assay. When cultured in vitro, BMSCs require dexametha-
sone (Dex) or other osteogenic inducers to undergo osteoblast
differentiation. We previously observed that human BMSCs cul-
tured without Dex in media with high levels of fetal bovine serum
(FBS, 16%) express low levels of alkaline phosphatase, and eas-
ily detach from the culture dishes after several weeks of culture.
We noted that BMSCs express gelatinases MMP-2 and MMP-9
and that Dex can inhibit gelatinase activity in different cell types.
As cell attachment was recently shown to promote osteogenesis,
we tested the hypothesis that BMSC cell attachment, collagen
ﬁbril assembly, and osteogenic differentiation is coupled to Dex-
dependent inhibition of gelatinases.
Methods: Conﬂuent BMSCs (Tulane Center for Genomics, LA)
from 4 distinct human donors were cultured in complete culture
media (CCM), mineralizing media (MM), or osteogenic media
(OSM). CCM consisted of α-MEM, 16% FBS, and 100 U/mL
penicillin/streptomycin. MM was composed of CCM with disodium
β-glycerol phosphate, L-ascorbic acid-2-phosphate, and cyclodex-
trin. OSM contained MM plus 10 nM or 100 nM Dex. The state
of cell differentiation was studied by Western blot or ELISA for
stem cell (CD105) and late osteoblast markers (osteonectin and
osteocalcin), and by in situ staining for alkaline phosphatase. The
production of a calciﬁed matrix was evaluated by Alizarin Red
staining. Immunohistochemistry for collagen type I was used to
analyze collagen ﬁbril organization. The release of total MMP-2
(pro- and active) to the conditioned media was analyzed by ELISA,
and gelatinase activity was studied by zymography.
Results: Human BMSCs after 3 cell passages consisted in partly
differentiated mesenchymal cells mixed with a precursor cell pop-
ulation that released total MMP-2 (D0, Fig. 1A) and activate gelati-
nases to the media. After 2 weeks of culture, Dex suppressed an
increase in total MMP-2 release (p<0.0001, Fig. 1A) and inhibited
all gelatinase activity. In cultures without Dex, BMSC monolayers
frequently detached from the dish and formed nodules with an
average 9 mg of wet mass compared to 1.3 mg wet mass in
cultures with Dex (p<0.0001). These nodules consisted in unique
structures of invaginated layers of collagen type I populated with
cells that formed a more cohesive network of collagen I ﬁbrils
with Dex (Fig. 1B). Dexamethasone stimulated osteoblastic differ-
entiation of adherent BMSC monolayers after 3 weeks of culture,
as assessed by an increase in alkaline phosphatase, osteocalcin,
and matrix calciﬁcation.
Figure 1. A. Total MMP-2 release to BMSC conditioned media at day 14 was
inhibited by Dex (D0 = Day 0). B. Tissue nodules immunostained for collagen
type I (red). Original mag. 5×.
Conclusions: Our results provide new evidence that Dex in-
duces osteogenic differentiation of human BMSCs in vitro partly
by inhibiting gelatinase activity which results in increased cell
attachment and differentiation.
